Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)

NCT01117220 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Placebo
DRUG: Ziprasidone Oral Capsules

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.